Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of Cannabidiol on Psychiatric and Medical Conditions
Thersilla Oberbarnscheidt, Norman S. Miller
Journal of Clinical Medicine Research (2020) Vol. 12, Iss. 7, pp. 393-403
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Cannabis: a multifaceted plant with endless potentials
Eric Fordjour, Charles F. Manful, Albert Adu Sey, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 46
Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
Giulia Abate, Daniela Uberti, Simone Tambaro
Biology (2021) Vol. 10, Iss. 6, pp. 542-542
Open Access | Times Cited: 71
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 18
CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
Lixuan Qian, Jessica L. Beers, Klarissa D. Jackson, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 484-484
Open Access | Times Cited: 6
Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials
Kyle McKee, Amira Hmidan, Candice E. Crocker, et al.
Journal of Psychiatric Research (2021) Vol. 140, pp. 267-281
Closed Access | Times Cited: 35
Cannabidiol interactions with oxycodone analgesia in an operant orofacial cutaneous thermal pain assay following oral administration in rats
Ariana C. Brice‐Tutt, Niall Murphy, Barry Setlow, et al.
Pharmacology Biochemistry and Behavior (2025) Vol. 250, pp. 173968-173968
Closed Access
Cannabidiol reverses myeloperoxidase hyperactivity in the prefrontal cortex and striatum, and reduces protein carbonyls in the hippocampus in a ketamine-induced schizophrenia rat model
Sofia de Almeida Queiroz, Linério Ribeiro de Novais Júnior, ANITA PACHECO, et al.
Schizophrenia Research (2025) Vol. 278, pp. 82-95
Closed Access
Cannabidiol alleviates valproic acid-induced developmental changes in mice pups: role of the allosteric modulation of the CB1 receptor in the regulation of the GABAergic system
Princewill Sopuluchukwu Udodi, Augustine Uche Agu, NtoJohnson Nto, et al.
Neuroscience and Behavioral Physiology (2025)
Closed Access
Cannabis as a Source of Approved Drugs: A New Look at an Old Problem
Adi Gabarin, Ludmila Yarmolinsky, Arie Budovsky, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7686-7686
Open Access | Times Cited: 12
P2X7 receptors from the perspective of NLRP3 inflammasome pathway in depression: Potential role of cannabidiol
Elif Akçay, Hülya Karataş
Brain Behavior & Immunity - Health (2024) Vol. 41, pp. 100853-100853
Open Access | Times Cited: 4
Cannabinoids for Agitation in Alzheimer's Disease
John D. Outen, M. Haroon Burhanullah, Ryan G. Vandrey, et al.
American Journal of Geriatric Psychiatry (2021) Vol. 29, Iss. 12, pp. 1253-1263
Open Access | Times Cited: 23
CBD enhances the cognitive score of adolescent rats prenatally exposed to THC and fine-tunes relevant effectors of hippocampal plasticity
Valentina Castelli, Gianluca Lavanco, Cesare D’Amico, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Effects of Cannabidiol and Beta-Caryophyllene Alone or in Combination in a Mouse Model of Permanent Ischemia
Cody G. Yokubaitis, Hassan N. Jessani, Hongbo Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2866-2866
Open Access | Times Cited: 15
Reducing Effect of Cannabidiol on Alcohol Self-Administration in Sardinian Alcohol-Preferring Rats
Paola Maccioni, Jessica Bratzu, Mauro A.M. Carai, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 2, pp. 161-169
Open Access | Times Cited: 15
Breast Cancer and Medical Imaging
Mohammed Erkhawan Hameed Rasheed, Mansour Youseffi
(2024)
Open Access | Times Cited: 1
Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders
Laura D. Carreira, Francisca C. Matias, María G. Campos
Biomedicines (2022) Vol. 10, Iss. 4, pp. 796-796
Open Access | Times Cited: 7
Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies
Divya Vimal, Leonard Clinton D’Souza, Vipin Rai, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 2, pp. 178-202
Closed Access | Times Cited: 6
Marijuana: An Underappreciated Risk Factor for Acute Type A Aortic Dissection?
Iam Claire E. Sarmiento, Ashley T. Giammarino, S. Jacob Scheinerman, et al.
The Heart Surgery Forum (2021) Vol. 24, Iss. 1, pp. E137-E142
Open Access | Times Cited: 8
A Review of On the Psychobiological Differences among Tetrahydrocannabinol, Cannabinol, Cannabidiol and Cannabigerol
Giusy Messina, Franco Rovelli, Paolo Lissoni
Clinical Reviews & Cases (2022) Vol. 4, Iss. 3
Open Access | Times Cited: 4
Cannabidiol and the central nervous system: translating into clinics
Antonio Saviano, F. Raucci, Martina Tallarico, et al.
(2021) Vol. 3, Iss. 2, pp. 369-369
Open Access | Times Cited: 4
Sustainable Hemp Products
Fieke Dhondt, Subramanian Senthilkannan Muthu
Sustainable textiles (2021), pp. 95-107
Closed Access | Times Cited: 4
Potencial terapêutico dos canabinoides em doenças neurodegenerativas: Parkinson, Alzheimer e Esclerose Múltipla
Brenda Winona dos Santos, Idonilton da Conceição Fernandes, Josiane de Fátima Gaspari Dias, et al.
Revista Eletrônica Acervo Saúde (2024) Vol. 24, Iss. 1, pp. e15296-e15296
Open Access
Opinions of French psychiatrists on the regulatory status of cannabis: Results from the “PsyCan – Encéphale” national online survey
Léa Leclerc, É. Fakra, Baptiste Pignon, et al.
L Encéphale (2024) Vol. 50, Iss. 6, pp. 597-602
Closed Access
The Role of Medicinal Cannabis as an Emerging Therapy for Opioid Use Disorder
Kelvin Le, Khang Duy Ricky Le, Johnny Nguyen, et al.
Pain and Therapy (2024) Vol. 13, Iss. 3, pp. 435-455
Open Access
Page 1 - Next Page

Scroll to top